Subcutaneous injection Subcutaneous injection remains the reference standard for peptide administration
Cellular signaling studies, tissue biology research, and gastrointestinal biology investigations are some of the areas that researchers are investigating regarding this peptide
Laboratory studies reveal TB-500 reduces production of inflammatory mediators including TNF- and IL-1 by 55% while enhancing anti-inflammatory IL-10 and TGF- expression, creating balanced immune responses that clear damaged tissue while supporting regeneration
Inventory is maintained to support ongoing laboratory supply requirements
Compared with subcutaneous injections, gluteal IM injections can accommodate larger volumes of medication and are often used for drugs that require deep muscle delivery or slow absorption
A new vial of BAC water is an insignificant expense compared to the time, cost, and effort that go into a research project